TY - JOUR
T1 - Influence of a 100-km ultra-marathon on hepatitis B carrier runners
AU - Chiu, Y. H.
AU - Hou, S. K.
AU - How, C. K.
AU - Li, L. H.
AU - Kao, W. F.
AU - Yang, C. C.
AU - Chou, S. L.
AU - Shiau, Y. T S
AU - Lam, C.
AU - Chen, R. J.
PY - 2013
Y1 - 2013
N2 - This study compares the serological markers between runners who are hepatitis B virus carries (HBVc) and runners who are non-HBVc in a 100-km ultra-marathon race. Blood samples of 8 HBVc and 18 non-HBVc runners were drawn 1 week before, immediately following, and 24 h after the race. Samples were analyzed and compared between the 2 groups for liver function tests, muscle damage markers and oxidative stress cytokines. For HBVc runners, HBV-DNA (hepatitis B virus-deoxyribonucleic acid) levels were also evaluated for virus reactivation. The results demonstrate a statistically significant increase in both immediate and 24-h post-race values for alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), compared with pre-race values. No statistically significant difference was observed between the 2 groups for the values of AST, LDH, CK, hs-CRP, IL-6 and TNF-α either before or after the race. There was also no statistically significant change in the levels of HBV-DNA in HBVc runners. These findings suggest that HBVc runners do not have higher risks of liver function impairment, muscle breakdown and inflammatory response compared to non-HBVc runners in such endurance races.
AB - This study compares the serological markers between runners who are hepatitis B virus carries (HBVc) and runners who are non-HBVc in a 100-km ultra-marathon race. Blood samples of 8 HBVc and 18 non-HBVc runners were drawn 1 week before, immediately following, and 24 h after the race. Samples were analyzed and compared between the 2 groups for liver function tests, muscle damage markers and oxidative stress cytokines. For HBVc runners, HBV-DNA (hepatitis B virus-deoxyribonucleic acid) levels were also evaluated for virus reactivation. The results demonstrate a statistically significant increase in both immediate and 24-h post-race values for alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), creatine kinase (CK), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), compared with pre-race values. No statistically significant difference was observed between the 2 groups for the values of AST, LDH, CK, hs-CRP, IL-6 and TNF-α either before or after the race. There was also no statistically significant change in the levels of HBV-DNA in HBVc runners. These findings suggest that HBVc runners do not have higher risks of liver function impairment, muscle breakdown and inflammatory response compared to non-HBVc runners in such endurance races.
KW - clinical sports medicine
KW - hepatitis B virus carrier runner
KW - inflammatory response
KW - liver function impairment
KW - ultra-marathon
UR - http://www.scopus.com/inward/record.url?scp=84883490249&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883490249&partnerID=8YFLogxK
U2 - 10.1055/s-0032-1331769
DO - 10.1055/s-0032-1331769
M3 - Article
C2 - 23444084
AN - SCOPUS:84883490249
SN - 0172-4622
VL - 34
SP - 841
EP - 845
JO - International Journal of Sports Medicine
JF - International Journal of Sports Medicine
IS - 9
ER -